Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Lixte Biotechnology Holdings, Inc. (LIXT) had Weighted-Average Shares Outstanding (Diluted) of 2.72M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.78M |
|
-- |
|
-- |
|
$0.77M |
|
$-0.77M |
|
$-0.00M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.77M |
|
$-0.77M |
|
2.72M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.72M |
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$0.99M |
|
-- |
|
$0.20M |
|
$1.19M |
|
$0.54M |
|
-- |
|
-- |
|
$0.54M |
|
$0.65M |
|
$0.65M |
|
$0.65M |
|
2.76M |
|
| Cash Flow Statement Financials | |
$-1.06M |
|
-- |
|
$0.90M |
|
$1.04M |
|
$0.89M |
|
$-0.15M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-119.07% |
|
-119.07% |
|
-65.26% |
|
-119.07% |
|
$0.24 |
|
$-0.39 |
|
$-0.39 |
|